Ibudilast: Phase II data

In a 2-year, double-blind, placebo-controlled, multiple-dose, European Phase II trial in 297 patients, MN-166 missed the primary endpoint of a reduction in the cumulative number of

Read the full 263 word article

How to gain access

Continue reading with a
two-week free trial.